8-(3-bromophenyl)-7,8-dihydro-1,3-dioxolo[4,5-g]quinolin-6(5H)-one | 714281-10-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 8-(3-bromophenyl)-7,8-dihydro-1,3-dioxolo[4,5-g]quinolin-6(5H)-one
• 英文别名: 8-(3-bromophenyl)-7,8-dihydro[1,3]dioxolo[4,5-g]quinolin-6(5H)-one；8-(3-bromophenyl)-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]quinolin-6-one
• CAS: 714281-10-4
• 化学式: C₁₆H₁₂BrNO₃
• 分子量: 346.18
• InChiKey: CBQBUJKRIFKPMJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  21
• 可旋转键数：
  1
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  47.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  间溴苯甲醛 、 3,4-亚甲二氧基苯胺 、 6,6-dimethyldihydro-2H-pyran-2,4(3H)-dione 在 ziconium(IV) oxychloride octahydrate 作用下， 以 neat (no solvent) 为溶剂， 反应 0.5h， 以92%的产率得到8-(3-bromophenyl)-7,8-dihydro-1,3-dioxolo[4,5-g]quinolin-6(5H)-one
  参考文献：
  名称：

  ZrOCl₂ · 8H₂O: An Efficient, Ecofriendly, and Recyclable Catalyst for Ultrasound-Accelerated, One-Pot, Solvent-Free Synthesis of 8-Aryl-7,8-dihydro-[1,3]dioxolo[4,5-g]quinolin-6-(5H)-one and 4-Aryl-3,4-dihydroquinolin-2(1 H)-one Derivatives

  摘要：

  A convenient, one-pot, solvent-free reaction of amines, aromatic aldehydes, and Meldrum's acid to form 8-aryl-7,8-dihydro-[1,3]dioxolo[4,5-g]quinolin-6-(5H)-one and 4-aryl-3,4-dihydroquinolin-2-(1H)-one in the presence of 10mol% ZrOCl2.8H(2)O under ultrasonic irradiation is described. This new protocol offers several advantages including low catalyst loading, clean reaction, easy workup, use of recyclable and ecofriendly catalyst, short reaction times, good yields, and solvent-free conditions. Supplemental materials are available for this article. Go to the publisher's online edition of Synthetic Communications (R) to view the free supplemental file.

  DOI：

  10.1080/00397911.2012.718026

文献信息

• Compounds, compositions and methods of inhibiting a-synuclein toxicity
  申请人：The Whitehead Institute for Biomedical Research

  公开号：EP2433634A2

  公开（公告）日：2012-03-28

  Compounds and compositions are provided for treatment or amelioration of one or more symptoms of a-synuclein toxicity, a-synuclein mediated diseases or diseases in which a-synuclein fibrils are a symptom or cause of the disease. In one embodiment, the compounds for use in the compositions and methods are heteroaryl acylguanidines, heteroarylhydrazones, dihydropyridones, heteroaryl and aryl styryl ketones, and heteroarylpyrazoles.

  提供的化合物和组合物用于治疗或改善a-突触核蛋白毒性、a-突触核蛋白介导的疾病或a-突触核蛋白纤维是症状或病因的疾病的一种或多种症状。在一个实施方案中，用于组合物和方法的化合物是杂芳基酰基胍、杂芳基肼、二氢吡啶酮、杂芳基和芳基苯乙烯基酮以及杂芳基吡唑。
• Azarifar, Davood; Sheikh, Davood, Acta Chimica Slovenica, 2012, vol. 59, # 3, p. 664 - 669,6
  作者：Azarifar, Davood、Sheikh, Davood

  DOI：——

  日期：——
• TETRAMERIC ALPHA-SYNUCLEIN AND USE THEREOF
  申请人：Ringe Dagmar

  公开号：US20130289022A1

  公开（公告）日：2013-10-31

  Disclosed herein are methods and related compositions for identifying compounds that stabilize natively folded tetrameric α-synuclein. These methods and compositions are useful for the treatment and diagnosis of α-synuclein-associated diseases and disorders.
• US9744171B2
  申请人：——

  公开号：US9744171B2

  公开（公告）日：2017-08-29
• [EN] POSITIVE ALLOSTERIC MODULATORS FOR MELANOCORTIN RECEPTORS<br/>[FR] MODULATEURS ALLOSTÉRIQUES POSITIFS POUR RÉCEPTEURS DE MÉLANOCORTINE
  申请人：UNIV VANDERBILT

  公开号：WO2013134376A1

  公开（公告）日：2013-09-12

  Positive allosteric modulators of melanocortin receptors, especially allosteric potentiators of the receptors MC3R and MC4R are described herein. Also provided are pharmaceutical compositions containing the positive allosteric modulators and methods of treating obesity or an obesity-related disorder such as type 2 diabetes, comprising administering an effective amount of the positive allosteric modulator.